Medical network on April 17 - medicine, your little heart ok? The first long confusion of health care products industry will face changes, health food, special medical use formula and three types of infant formula food special food will strictly regulated by the new department. Is again, couplet of medical era coming, the high quality resources must be sinking at the grass-roots level, hierarchical diagnosis must push strength, couplet of medicine must be closer connection. Finally, and most of the blockbuster, 44 varieties of price negotiation, into the may start to worry whether the price, not into more regret extremely. Trillions of medical market storm upgrade! 

 

Blockbuster! People club department 44 varieties of price negotiation 

 

On April 14, people club department issued "about 2017 national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue negotiations range of circular. With the spread of 45 kinds of plans to negotiate drug, finalized into health care medicine directory negotiations as 44 varieties, including imported varieties 25, 19 domestic varieties. Specific see table: 

 

 

 

The new department! The CFDA set up special food registration management 

 

Recently, the national food administration of drug safety has internal dispatch, special food for the long-simmering registration management was formally established, is expected to will soon be released. According to the new food safety law provisions of article seventy-four, special food including health food, medical use special formula and infant formula, the three kinds of food to more stringent supervision and management. So-called "regulation", means a higher entry barrier, such as general food production to achieve "production license", apply in local government departments, while the three kinds of special food to eat drug safety administration of application for registration, and the more stringent conditions. 

 

Health care reform want to play hardball. Construction of the state council executive meeting of the deployment of medical association 

 

In Beijing on April 12, the state council premier li keqiang chaired a state council executive meeting, the deployment of pushing forward the construction of the medical association in order to deepen the reform of the systems and mechanisms for the masses to provide high quality medical services. This is a very strong signals from the upper, high-quality resources must be sinking at the grass-roots level, hierarchical diagnosis must push strength, couplet of medicine must be closer connection. 

 

Couplet of medical conference pointed out that the construction and development, is to carry out the people centered development thought, to carry out the "government work report" deployment of the key tasks, is deepening the reform of medical health care medicine linkage, the rational allocation of resources, make people enjoy convenient high quality medical services. 

 

Break down barriers Full swing 

 

One to break the administrative area, financial investment, health care payments, personnel management, as well as the barriers to full launch of couplet of various kinds of medical construction pilot. Adjust measures to local conditions to explore by tertiary public hospital or business ability strong, county hospital, hospital, set up different levels, different types of urban and rural medical institutions or specialized subject of complementary advantages, collaboration between medical couplet, vigorously develop for telemedicine network and outlying and poverty-stricken areas at the grass-roots level. 

 

Resource sink check mutual recognition 

 

Second, we must promote high quality medical resources sharing and sink at the grass-roots level, by sending experts, specialized subject to build, enhance the level of primary care business guidance, etc. Implementation within the couplet of medical health records, medical records, such as connectivity, implement results mutual recognition, prescription drugs, sharing. Based on medical image, inspection center, such as integration services in the couplet of medical. Also must strengthen the cooperation between different medical couplet body. 

 

To sign up the family doctor for the gripper 

 

Third, we need to speed up the implementation of hierarchical diagnosis mechanism. Demand oriented old-age signing the family doctor service, all the poor into the scope of services during the year. Encourage and guide the residents to the first option, the superior hospital signed a contract to provide priority accepts, examination, hospitalization and other services, and postoperative recovery time, such as severe plateau patient referral down channel. Encourage nursing center, professional to join the medical rehabilitation institutions. 

 

Grassroots ZhenLiaoLiang proportion into the KPI 

 

Fourth, we need to increase policy support. Explore the incentive mechanism is advantageous to the up and down through the allocation of health resource. Total of vertical cooperation medical couplet of medicare pay pay for a variety of ways. The grassroots ZhenLiaoLiang percentage than, two-way referral, residents health improvement indicators into the performance appraisal, etc. Medical staff in medical couplet body flow in practice generally do not need to deal with relevant formalities. To reform and innovation better satisfy the crowd disease prevention, convenient for medical treatment and nursing, rehabilitation, etc. 

 

Pharmaceutical, medical device registration fraud will face the most severe punishment 

 

On April 10, to the supreme judge committee plenary meeting and by the supreme people's court, the supreme people's procuratorate about deal with drugs, medical devices registration data fraud criminal cases to explain some issues of applicable law, the requirement of drugs and medical device registration data fraud will face a convicted and punished. 

 

"Explain" SongShenGao three kinds of situations has been clear about the relevant registration fraud charges: 

 

1, drug non-clinical research institutions, drug or medical device clinical test units, contract research organization deliberately provides false non-clinical study, clinical test report, can be convicted and punished by providing false documents sin; 2, for drug registration applicant fraud, providing false non-clinical research or clinical test report and related materials, diddle drug approval documents, can be convicted and punished according to the production, the sale fake sin; 3, drug non-clinical research institutions, drug or medical device clinical test units, contract research organization, with the drug registration applicant provides false non-clinical research or clinical test report and related materials, diddle drug approval documents, at the same time, make crime of providing false documents and production, sales, the crime of counterfeit, convicted and punished for heavier punishment crime. 

 

Drug clinical trial data verification six Suggestions have been adopted 

 

Released on April 10, the CFDA solicit public again on the drug clinical trial data verification issues related to disposal announcement (amended) "(hereinafter referred to as" notice "). "Announcement" mentioned, in 2016 September 8 - solicit opinions from the drug clinical trial data verification issues related to processing, received the pharmaceutical enterprises, medical institutions, contract research organization and industry associations and other unit and individual feedback on 280. As a result, administration of the state food and drug supervision and administration combined with modified feedback, among them, have been adopted in the reasonable opinion suggestion, mainly summarized six, not accepted opinion is summarized as three. 

 

Details can be found: CFDA again for advice: drug clinical trial data verification six Suggestions have been adopted 

 

Hunan to implement two votes, water drain medicine circulation field 

 

On April 11, health and family planning commission of hunan province held a press conference, issued by the health department, provincial health development planning commission of hunan province, the provincial development and reform commission, provincial nine departments jointly issued by letter committee, etc of the public medical institutions of hunan province drug purchase "two votes" implementation plan (try out) "(hereinafter referred to as" implementation plan "), a clear from April 1, the entire province all public medical institutions, including the provinces do grassroots medical institutions and drug procurement to implement the "two votes". 

 

"Implementation plan" requirement, pharmaceutical production, circulation enterprises sell drugs shall be in accordance with the related provisions of invoice management, issue special VAT invoice or commercial invoice. Buy medicine circulation enterprises should take the initiative to ask for bill to the production enterprise. Public medical institutions in drug check incoming, not only to charge distribution pharmaceutical circulation enterprises, verify the invoice, also should be required to issue purchase invoice provided by the production enterprise circulation enterprises copy or scanning electron parts, in order to confirm each other. 

 

Six Chinese medicine new medicine clinical research technical guidelines for advice on the Internet 

 

Released on April 13, the CFDA "about six Chinese medicine new medicine clinical research technical guidelines to get to the Internet for advice notice. Drug approval center in August 2016 launched the first batch of Chinese traditional medicine new drug clinical research technical guidelines has completed preliminary draft work, now on the Internet for public opinion. The advice of six guiding principles for the new drug for irritable bowel syndrome of traditional Chinese medicine clinical research technical guiding principles, the traditional Chinese medicine new drug used for functional dyspepsia clinical research technical guiding principles, the Chinese medicine new medicine for cough variant asthma clinical research technical guiding principles, the Chinese medicine new medicine clinical research technical guiding principles for rheumatoid arthritis, the Chinese traditional medicine new drug for chronic heart failure clinical research technical guiding principles, the clinical research of TCM new drugs for dementia technical guiding principles. 

 

Forbes China released "2017 potential Chinese companies list" 

 

Forbes China recently released "2017 China list of potential companies, for the first time presents a list of potential companies of listed companies and unlisted companies list of potential companies and notable new three board enterprise list, which is high on the list of potential public listed companies 100, 100 potential new three board enterprises, 20 potential of private enterprises, a total of 220 companies. Among them, 220 companies have high on the list of the 30 companies medical health field. 22 for the pharmaceutical industry enterprises, eight for diagnostic reagents, diagnosis and treatment equipment, medical auxiliary equipment, etc. Specific list can click: 2017 Forbes list of potential companies in China, this 30 medical health care companies on the list 

 

1.657 billion yuan, the year big health yu actual control people melt Wan Dong medical 22% stake 

 

On April 10, Wan Dong medical announcement said, diving technology has reached an agreement with Mr Beauty in great health shu melting, diving technology will be 22% of the total equity stake in the price of $19.50 per share transfer by way of contract transfer to Mr Yu fusion, deal price is about 1.657 billion. Notice at the same time, according to yu melt direct or indirect stakes in listed companies in the health, 30.19% for the actual controllers of the company.